This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jackson, E. K. Articles by Herzer, W. A. Search for Related Content PubMed PubMed Citation Articles by Jackson, E. K. Articles by Herzer, W. A.

Hypertension, Vol 23, 329-336, Copyright © 1994 by American Heart Association

ARTICLES

Defective modulation of angiotensin II-induced renal vasoconstriction in hypertensive rats

EK Jackson and WA Herzer
Center for Clinical Pharmacology, University of Pittsburgh Medical Center, PA 15261.

In a previous study we observed that the ability of intravenous infusions of prostaglandin I2 to attenuate vasoconstriction caused by intravenous infusions of angiotensin II was reduced in the renal but not mesenteric vasculature of spontaneously hypertensive rats (SHR). One objective of the current study was to determine whether a renal defect in the angiotensin II/prostaglandin I2 interaction in SHR could be confirmed even when confounding hemodynamic changes induced by intravenous infusions of prostaglandin I2 were avoided. The second objective was to determine whether abnormal modulation of angiotensin II-induced renal vasoconstriction was present even in SHR that were maintained normotensive from an early age. Four-week-old SHR and normotensive Wistar-Kyoto rats were randomized to receive either normal drinking water or drinking water containing captopril (100 mg/kg per day). At 14 to 18 weeks of age, rats were pretreated with indomethacin to block the production of endogenous prostaglandin I2, and changes in mesenteric and renal vascular resistances induced by suprarenal/supramesenteric aortic infusions of angiotensin II (10, 30, and 100 ng/kg per minute) were elicited in the presence and absence of aortic infusions of prostaglandin I2 (0.1 and 0.3 micrograms/kg per minute). Data were analyzed globally using four- and three-factor ANOVAs. The ability of prostaglandin I2 to attenuate the renal vasoconstrictor response to angiotensin II was strain specific (P = .0138), and this strain-specific interaction was not influenced by chronic treatment with captopril (P = .3526).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867. [Abstract] [Full Text] [PDF]

				O. Vagnes, J. J. Feng, B. M. Iversen, and W. J. Arendshorst Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension Am J Physiol Renal Physiol, June 1, 2000; 278(6): F940 - F948. [Abstract] [Full Text] [PDF]

				E. K. Jackson, W. A. Herzer, Z. Mi, S. J. Vyas, and C. K. Kost Jr Low-Dose Angiotensin II Reduces Urinary Cyclic AMP Excretion in Spontaneously Hypertensive, But Not Normotensive, Rats: Independence from Hypertension and Renal Hemodynamic Effects of Angiotensin J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 115 - 123. [Abstract] [Full Text]

				E. K. Jackson, W. A. Herzer, S. J. Vyas, and C. K. Kost Jr Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 329 - 334. [Abstract] [Full Text]

				B. M. Iversen and W. J. Arendshorst Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F260 - F270. [Abstract] [Full Text] [PDF]

				R. Mokkapatti, S. J. Vyas, G. G. Romero, Z. Mi, T. Inoue, R. K. Dubey, D. G. Gillespie, A. K. Stout, and E. K. Jackson Modulation by Angiotensin II of Isoproterenol-Induced cAMP Production in Preglomerular Microvascular Smooth Muscle Cells from Normotensive and Genetically Hypertensive Rats J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 223 - 231. [Abstract] [Full Text]

				S. J. Vyas, R. Mokkapatti, R. K. Dubey, M. R. Chinoy, and E. K. Jackson Guanine Nucleotide-Binding Inhibitory Protein-Mediated Inhibition of Adenylyl Cyclase Is Enhanced in Spontaneously Hypertensive Rat Preglomerular Arteriolar Smooth Muscle Cells J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 828 - 834. [Abstract] [Full Text]